MedPath

Lycopene

Generic Name
Lycopene
Drug Type
Small Molecule
Chemical Formula
C40H56
CAS Number
502-65-8
Unique Ingredient Identifier
SB0N2N0WV6
Background

Lycopene is a naturally occuring red carotenoid pigment that is responsible in red to pink colors seen in tomatoes, pink grapefruit, and other foods . Having a chemical formula of C40H56, lycopene is a tetraterpene assembled from eight isoprene units that are solely composed of carbon and hydrogen. Lycophene may undergo extensive isomerization that allows 1056 theoretical cis-trans configurations; however the all-trans configuration of lycopene is the most predominant isomer found in foods that gives the red hue. Lycopene is a non-essential human nutrient that is classified as a non-provitamin A carotenoid pigment since it lacks a terminal beta ionone ring and does not mediate vitamin A activity. However lycophene is a potent antioxidant molecule that scavenges reactive oxygen species (ROS) singlet oxygen. Tomato lycopene extract is used as a color additive in food products.

Indication

Not Available

Associated Therapies
Nutritional supplementation

Evaluation of Lycopene in the Treatment of Erosive Oral Lichen Planus

Phase 2
Completed
Conditions
Erosive Lichen Planus
Interventions
First Posted Date
2020-12-03
Last Posted Date
2020-12-03
Lead Sponsor
Nourhan M.Aly
Target Recruit Count
20
Registration Number
NCT04652739
Locations
🇪🇬

Faculty of Dentistry, Alexandria University, Alexandria, Egypt

Lycopene vs Minocycline Hydrochloride as Adjunctive to Periodontal Treatment

Phase 2
Conditions
Periodontal Pocket
Interventions
First Posted Date
2019-05-28
Last Posted Date
2019-05-28
Lead Sponsor
University of Baghdad
Target Recruit Count
30
Registration Number
NCT03964935
Locations
🇮🇶

College of Dentistry/ University of Baghdad, Baghdad, Iraq

Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis

Phase 1
Completed
Conditions
Chronic Periodontitis
Interventions
Procedure: SRP only
First Posted Date
2017-06-29
Last Posted Date
2017-06-29
Lead Sponsor
Maie Sami tawfik
Target Recruit Count
24
Registration Number
NCT03203746

Panitumumab Skin Toxicity Prevention Trial

Phase 2
Conditions
Skin Toxicity
Colorectal Cancer Metastatic
Interventions
Other: Placebo
First Posted Date
2017-05-25
Last Posted Date
2021-09-09
Lead Sponsor
Ospedale San Carlo Borromeo
Target Recruit Count
28
Registration Number
NCT03167268
Locations
🇮🇹

Marco Pirovano, Milano, Italy

A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus

Phase 4
Completed
Conditions
Oral Lichen Planus
Interventions
First Posted Date
2015-10-27
Last Posted Date
2016-02-26
Lead Sponsor
B.P. Koirala Institute of Health Sciences
Target Recruit Count
28
Registration Number
NCT02587117

Docetaxel and Lycopene in Metastatic Prostate Cancer

Phase 1
Completed
Conditions
Adenocarcinoma of the Prostate
Interventions
First Posted Date
2013-09-24
Last Posted Date
2018-01-11
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
24
Registration Number
NCT01949519
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

🇺🇸

Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, United States

The Effects of Lycopene on High Risk Prostatic Tissue

Phase 2
Completed
Conditions
Prostatic Neoplasms
Intraepithelial Prostatic Neoplasia
Interventions
Drug: Placebo
First Posted Date
2011-09-29
Last Posted Date
2019-11-19
Lead Sponsor
University of Illinois at Chicago
Target Recruit Count
66
Registration Number
NCT01443026
Locations
🇺🇸

Jesse Brown VA Medical Center, Chicago, Illinois, United States

🇺🇸

Northwestern Memorial Hospital, Chicago, Illinois, United States

Lycopene Following Aneurysmal Subarachnoid Haemorrhage

Phase 2
Conditions
Subarachnoid Hemorrhage
Aneurysm
Interventions
Drug: placebo
First Posted Date
2009-05-21
Last Posted Date
2010-06-11
Lead Sponsor
University of Cambridge
Target Recruit Count
124
Registration Number
NCT00905931
Locations
🇬🇧

Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom

Treatmant of Oral Lichen Planus With Lycopene

Phase 2
Completed
Conditions
Lichen Planus, Oral
Interventions
Drug: Placebo
First Posted Date
2008-04-10
Last Posted Date
2008-04-10
Lead Sponsor
College of Dental Sciences, India
Target Recruit Count
30
Registration Number
NCT00656214
Locations
🇮🇳

Department of oral medicine & radiology, College of dental sciences, Davangere, Karnataka, India

Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer

Phase 2
Completed
Conditions
Adenocarcinoma of the Prostate
Stage I Prostate Cancer
Stage II Prostate Cancer
Stage III Prostate Cancer
Interventions
Other: placebo
Procedure: therapeutic conventional surgery
Other: laboratory biomarker analysis
First Posted Date
2007-03-22
Last Posted Date
2019-12-18
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
10
Registration Number
NCT00450749
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath